Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Apr 2017 10:50

RNS Number : 5275B
Ergomed plc
04 April 2017
 

Ergomed Plc

("Ergomed" or the "Company")

 

Director Dealing

 

Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 3 April 2017, Mr Peter George, Chairman of the Company, bought 100,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share. Following this transaction, Mr Peter George holds 231,250 (0.6 per cent. of the Company's issued share capital).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter George

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 GB00BN7ZCY67

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

190p

100,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

100,000

190p

£190,000

f)

Date of the transaction

03 April 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

 

Ergomed Plc

Tel: +44 (0) 1483 503205

Miroslav Reljanovic (Chief Executive Officer)

Stephen Stamp (Chief Financial Officer)

 

Numis Securities (Nominated Advisor and Broker)

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Joint Broker)

 

Stifel Nicolaus Europe Limited

Tel: +44 (0) 20 7710 7600

Jonathan Senior (Joint Broker)

 

FTI Consulting (Financial PR)

Tel: +44 (0) 20 3727 1000

Simon Conway / Mo Noonan / Natalie Garland-Collins

MC-Services - for Continental European enquiries

Tel: +49 211 52925222

Anne Hennecke

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDMGGDLDLGNZG
Date   Source Headline
2nd Apr 20207:00 amRNSUpdate on Siltuximab Clinical Study
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 20204:36 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSErgomed’s PrimeVigilance Supports COVID-19 Trial
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 202012:44 pmEQSEdison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
25th Mar 20207:00 amRNSAudited full year results
18th Mar 20208:39 amRNSErgomed Announces COVID-19 Clinical Study
4th Mar 20207:00 amRNSNotice of Preliminary Results
2nd Mar 20207:00 amRNSTotal Voting Rights
18th Feb 20203:19 pmRNSHoldings in Company
14th Feb 20207:00 amRNSDirector/PDMR Shareholding
7th Feb 20207:00 amRNSExercise of Share Options and Total Voting Rights
3rd Feb 20205:45 pmRNSHoldings in Company
30th Jan 20207:00 amRNSAward of Share Options
30th Jan 20207:00 amRNSExercise of Share Options and Total Voting Rights
29th Jan 20207:00 amRNS2019 Trading Update
20th Jan 20204:13 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSCOO, Lewis Cameron, joins Ergomed
17th Jan 20207:00 amRNSExercise of Options
13th Jan 20207:00 amRNSAcquisition of Ashfield Pharmacovigilance Inc.
2nd Jan 20207:00 amRNSTotal Voting Rights & Block Listing Return
19th Dec 201911:59 amRNSBlock Listing Application
2nd Dec 20197:00 amRNSAppointment of Chief Operating Officer
2nd Dec 20197:00 amRNSTotal Voting Rights
19th Nov 201910:30 amRNSHolding(s) in Company
14th Nov 20195:24 pmRNSHolding(s) in Company
8th Nov 20193:43 pmRNSHolding(s) in Company
8th Nov 20193:41 pmRNSHolding(s) in Company
7th Nov 20197:00 amRNSDirector's Dealing
1st Nov 20194:41 pmRNSSecond Price Monitoring Extn
1st Nov 20194:35 pmRNSPrice Monitoring Extension
1st Nov 20197:00 amRNSTotal Voting Rights
1st Oct 20197:00 amRNSTotal Voting Rights
25th Sep 20197:00 amRNSBoard Change
25th Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSBoard Change
2nd Sep 20197:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSNotice of Interim Results
20th Aug 20197:00 amRNSBoard Appointment
1st Aug 20197:00 amRNSTotal Voting Rights
26th Jul 20193:30 pmRNSHolding(s) in Company
24th Jul 20198:04 amRNSDirector/PDMR Shareholding
23rd Jul 20193:19 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSBoard Appointments
22nd Jul 20197:00 amRNSErgomed H1 2019 Trading Update
19th Jul 20197:05 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSHoldings in Company
10th Jul 20197:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.